The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
S1605: Phase II trial of atezolizumab in BCG-unresponsive non-muscle invasive bladder cancer.
 
Parminder Singh
Honoraria - Genentech
Consulting or Advisory Role - GNS Healthcare
Speakers' Bureau - GNS Healthcare
 
Tangen Catherine
No Relationships to Disclose
 
Seth P. Lerner
Consulting or Advisory Role - BioCancell; Ferring; Nucleix; Sitka; Taris BioMedical; Telesta Therapeutics; Urogen pharma; Vaxiion
Research Funding - Endo Pharmaceuticals; FKD Therapies; JenaValve; Roche/Genentech; Viventia Biotech
Travel, Accommodations, Expenses - BioCancell; Ferring; Oncogenex; Urogen pharma
 
David McConkey
No Relationships to Disclose
 
Melissa Plets
No Relationships to Disclose
 
M. Scott Lucia
No Relationships to Disclose
 
Michael Woods
No Relationships to Disclose
 
Trinity Bivalacqua
No Relationships to Disclose
 
Wassim Kassouf
No Relationships to Disclose
 
Richard Carlton Bangs
Consulting or Advisory Role - Telesta Therapeutics
Travel, Accommodations, Expenses - Telesta Therapeutics
Other Relationship - National Cancer Institute
 
Ian Murchie Thompson
No Relationships to Disclose
 
Peter C. Black
Consulting or Advisory Role - Abbvie; Amgen; Astellas Pharma; Bayer; BioCancell; Biosyent; Cubist; Ferring; Janssen Oncology; Lilly; Merck; Novartis; Roche Canada; Sanofi; Sitka; Spectrum Pharmaceuticals
Speakers' Bureau - Ferring; Red Leaf Medical
Research Funding - iProgen; New B Innovation
Patents, Royalties, Other Intellectual Property - 1. PCT/CA2014/000787. Canada. 2014-11-03 Cancer Biomarkers and Classifiers and uses thereof. 2. #61899648 United States. 2013-03-13 Bladder cancer signature.
Travel, Accommodations, Expenses - Bayer; Janssen; Sanofi